The postponement suggests management is struggling to gather enough votes for the extension. Monitor the outcome of the October 23 vote closely — failure to pass the extension would likely lead to SPAC liquidation and a return of trust proceeds, while passage buys time for a deal announcement.
Price Chart
Executive Summary
Oaktree Acquisition Corp. III Life Sciences (OACC) postponed its extraordinary general meeting from October 16 to October 23, 2026, to allow more time for proxy solicitation on a proposal to extend the deadline for completing a business combination. The postponement signals potential difficulty in securing sufficient shareholder support for the extension, which is critical for the SPAC to avoid liquidation.
Key Financial Metrics
Key Facts
- General meeting postponed from October 16 to October 23, 2026.
- Meeting is to vote on a proposal to extend the deadline for OACC to complete a business combination.
- Postponement was approved by the extension committee of the board to permit further solicitation and vote of proxies.
- Record date remains September 22, 2026.
- Shareholders may continue to request withdrawal of redemption of Class A ordinary shares until the rescheduled meeting.
- Proxy solicitor Sodali & Co is engaged to assist with solicitation.
Financial Impact
No financial figures disclosed; the extension vote is existential for the SPAC — failure to pass could trigger liquidation and return of trust proceeds to shareholders.
Risk Factors
- Shareholders may vote against the extension, leading to liquidation of the SPAC.
- Continued inability to find a target business combination within the extended timeline.
- Redemption requests may reduce trust assets, making a future deal less attractive.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-423331 |
| Document: 0001193125-26-423331-index-headers.html | 0001193125-26-423331 |
| Document: 0001193125-26-423331-index.html | 0001193125-26-423331 |
| Document: 0001193125-26-423331.txt | 0001193125-26-423331 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $10.71 | awaiting T+1 | — | $10.68 (+0.28%) |
Oct 16, 2026 11d ago | DEFA14A | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.68 (+0.19%) |
Oct 16, 2026 11d ago | 8-K | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.68 (+0.19%) |
Oct 15, 2026 12d ago | DEFA14A | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.68 (−0.28%) |
Oct 15, 2026 12d ago | 8-K | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.68 (−0.28%) |
Oct 2, 2026 25d ago | DEF 14A | $10.76 $10.76 | · 0.00% | ▼ −0.55% | $10.68 (−0.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers